Pyridone A2R antagonists

Compound that inhibit at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorde...

Full description

Saved in:
Bibliographic Details
Main Authors MANDAL, Debashis, LELETI, Manmohan Reddy, POWERS, Jay Patrick, MILES, Dillon Harding, ROSEN, Brandon Reid, SHARIF, Ehesan Ul
Format Patent
LanguageEnglish
Published 18.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Compound that inhibit at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.
AbstractList Compound that inhibit at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.
Author POWERS, Jay Patrick
ROSEN, Brandon Reid
MANDAL, Debashis
MILES, Dillon Harding
LELETI, Manmohan Reddy
SHARIF, Ehesan Ul
Author_xml – fullname: MANDAL, Debashis
– fullname: LELETI, Manmohan Reddy
– fullname: POWERS, Jay Patrick
– fullname: MILES, Dillon Harding
– fullname: ROSEN, Brandon Reid
– fullname: SHARIF, Ehesan Ul
BookMark eNrjYmDJy89L5WSQCKgsykwBMhUcjYIUEvNKEtPz8zKLS4p5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8Y6iRgaGlsaGRkaWZo6ExcaoALmUkjQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2019312296A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2019312296A13
IEDL.DBID EVB
IngestDate Fri Oct 25 05:42:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2019312296A13
Notes Application Number: AU20190312296
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210318&DB=EPODOC&CC=AU&NR=2019312296A1
ParticipantIDs epo_espacenet_AU2019312296A1
PublicationCentury 2000
PublicationDate 20210318
PublicationDateYYYYMMDD 2021-03-18
PublicationDate_xml – month: 03
  year: 2021
  text: 20210318
  day: 18
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies ARCUS BIOSCIENCES, INC
RelatedCompanies_xml – name: ARCUS BIOSCIENCES, INC
Score 3.3231826
Snippet Compound that inhibit at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Pyridone A2R antagonists
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210318&DB=EPODOC&locale=&CC=AU&NR=2019312296A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NS8Mw9DGmqDedytQpBaW3IknTpj0M6frBELaVscluo11SGYx2rBXx3_tSOt1pt5DAS_LgfX8BvAiTIz_MMkN59Q2Wcmq4mckMQiRZkSSVVqIiuqOxPZyz94W1aMFmXwtT9wn9rpsjIkWtkN6rml9v_51YQZ1bWb6ma9wq3qJZP9Ab65iqoQWOHgz6YTwJJr7u-2hJ6uOpcgW6JqHUtT20lU5QkeaKHsKPgapL2R4KlegSTmOEl1dX0JJ5B879_ey1DpyNmpA3LhvqK6-hG__s1qLIpebRqYYoST4L1fi2vIHnKJz5QwOvWP79aOnND99j3kIbbX3ZBc0WruXwhDEzVb3yhMMsVH9NYVNHJJyTO-gdg3R__PgBLhSOVAoVcXrQrnZf8hFlapU-1aj4Bbe4d0o
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcChVrDetStWqASW3IJtsXociaR5EbdJQUuktJE1SCpKUJiL-vbMh1Z56W3Zhdndg3i-Ap1RSkR_mucC8-gJNVFHQc4kKhGRkSeIkk2MW0fV8xZ3Tt4W86MDnrham6RP63TRHRIpaIr3XDb_e_DuxrCa3snpO1rhVvjjhyOJb61hkQws03hqP7GBqTU3eNNGS5P0ZcwXqEhFFXTHQVjpCJVtl9GB_jFldymZfqDhncBwgvKI-h05W9KFn7mav9eHEa0PeuGypr7qAQfCzXadlkXGGOOMQJfGqZI1vq0t4dOzQdAW8Ivr7UWTM998jXUEXbf1sAJyS6rKmxpRKCeuVl2pURvVXShVRS2NVJdcwPATp5vDxA_Tc0JtEk1f__RZOGb5YOhXRhtCtt1_ZHcrXOrlv0PILem96PQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pyridone+A2R+antagonists&rft.inventor=MANDAL%2C+Debashis&rft.inventor=LELETI%2C+Manmohan+Reddy&rft.inventor=POWERS%2C+Jay+Patrick&rft.inventor=MILES%2C+Dillon+Harding&rft.inventor=ROSEN%2C+Brandon+Reid&rft.inventor=SHARIF%2C+Ehesan+Ul&rft.date=2021-03-18&rft.externalDBID=A1&rft.externalDocID=AU2019312296A1